Syros Pharmaceuticals, Inc. Annual Interest Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2023.
  • Syros Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2024 was $1.38M, a 8.14% increase year-over-year.
  • Syros Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2024 was $5.32M, a 13.9% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2023 was $5.13M, a 24% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2022 was $4.13M, a 5.81% increase from 2021.
  • Syros Pharmaceuticals, Inc. annual Interest Expense for 2021 was $3.91M, a 118% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.13M +$993K +24% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $4.13M +$227K +5.81% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $3.91M +$2.12M +118% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $1.79M +$1.72M +2389% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $72K -$928K -92.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $1M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.